Phibro Animal Health | PAHC - Ebit


Phibro Animal Health reported $54.99M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Align Technology USD 224.71M 40.06M Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -35.79M 8.96M Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -12.66M 1.64M Dec/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Henry Schein USD 186M 12M Dec/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Merck USD 6.24B 1.32B Dec/2025
Nektar Therapeutics USD -34.34M 3.68M Sep/2024
Pacira USD 3.19M 9.96M Dec/2025
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 82.49M 2.82M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
Zoetis USD 835M 140M Dec/2025